After two decades of growth driven largely by scale and generics, 2025 proved to be a reset year for India’s pharmaceutical, healthcare and medical devices sectors. Policy reform, a renewed focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results